Navigation Links
Biofeedback Found To Reduce Steroid Dependence In Asthmatics

Biofeedback is the conscious control of body functions through the use of electronic monitoring devices. A new study finds practicing daily biofeedback // can help people with asthma reduce their need for inhaled steroid medications.

Researchers tested the therapy in 94 adults with moderate persistent asthma. The participants were divided into four groups. Two of the groups used a biofeedback device that provided information about their heart rate variability( HRV). HRV was selected for the study because previous research has shown asthmatics have decreased HRV. Increasing HRV can improve respiratory symptoms.

In addition to the biofeedback, one group also learned to use a special pursed-lip breathing technique during their biofeedback sessions. A third group received a placebo, or sham, biofeedback therapy, and a fourth group received no treatment at all and served as controls. The three biofeedback groups participated in 10 weekly sessions and also practiced the technique at home for 20 minutes twice a day. All participants had regular checkups and kept a record of daily asthma symptoms.

People in both of the HRV biofeedback groups reduced the amount of inhaled steroid medication they needed to keep their asthma under control. Asthma severity also dropped from moderate persistent to mild persistent. Asthma symptoms improved in all three therapy groups, but the group that got the sham biofeedback therapy did not see a reduction in medication use or disease severity. No changes were noted in the control group.

Thus researchers say that they believe their findings suggest HRV biofeedback may prove to be a useful adjunct to asthma treatment and may help to reduce dependence on steroid medications.
'"/>




Page: 1

Related medicine news :

1. Biofeedback Treats One Type Of Chronic Constipation
2. Fluoride Found Effective in Osteoporosis
3. Implantable Contact Lens Found Safe and Effective
4. Cancer hazard Found With Animal-Based Nutrients
5. Processed Meat, Diabetes connection Found
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
9. Preventive Therapies Found to be More Effective in Managing Migraines
10. Common Cold Found to Fight Cancer
11. Circumcision Found To Prevent HIV Spread
Post Your Comments:
(Date:10/7/2008)...recommendations reflect previously published ACSM/... /PRNewswire-USNewswire/ -- Guidelines,for physica...f Health and,Human Services (HHS) were met with su... (ACSM) and the American Heart Association (AHA). ...l activity recommendations,last year, attended tod...
(Date:10/7/2008)...NGTON, Oct. 7 /PRNewswire-USNewswire/ -- Kristi Ya...ner of Dancing With the Stars, has been,named chai...istmas Seals,Campaign in an effort to help raise f...prevent lung disease and promote lung health., Th...ion began in 1907,to conquer Tuberculosis. Today, ...
(Date:10/7/2008)...ly to feel distress, more likely to enjoy better q... Oct. 7 (HealthDay News) -- End-of-life discussion... not result in more distress for patients. In fact...ions and enhanced quality of life in a patient,s f... past two decades, the debate has been around when...
(Date:10/7/2008)...se announcement of planned bequest comes at stem c...re-USNewswire/ -- Just over one year,ago, retail p...ift to the,University of Michigan, to endow a new ...g and preventing human disease., Today, at the in...uncing that he will bequeath an additional $22 mil...
Breaking Medicine News(10 mins):Health News:ACSM, AHA Support Federal Physical Activity Guidelines 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Alfred Taubman Announces New $22M Gift to U-M 2
...certain chemicals has been known to be associated ...etc. from time immemorial. But it is known not unt...eased // following occupational exposure to minera...matiod factor remains unestablished. However, a nu...
...w kind of rat that will help them to study the eff... women that can lead to hypertension and heart fai... of Medicine // have created a better research rat...olved in hypertension. These rats will allow them ...
...iversity in New York are under investigation for a...esearch studies and filing false information on pr...th (NIH) to maintain government funding for a univ...cher at the pediatric center accused the center’s ...
...logical levels free radicals and antioxidants in d...ell established following our improved understandi...ential scope because of the fact that confirmation...that treatment for such disorders can be made very...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2
(Date:10/7/2008)...ss., Oct. 7 /- Taligen Therapeutics I...f the Company,s pipeline,candidates were presented...Basel, Switzerland. The data highlighted the candi...ment-mediated diseases., "These highlighted prese...ented at the conference, reveal the deep expertise...
(Date:10/7/2008)...pective Randomized Placebo-Controlled Phase II Stu...ed Overall Survival., MOUNTAIN VIEW, California, ...s now evaluated the mature Phase II data from the,...TVAC(TM) that had been,obtained as part of the rec... Institute (NCI) in the US., The results from the...
(Date:10/7/2008)...nded to Eight On-Demand Tests for Use on the GeneX...UNNYVALE, Calif., Oct. 7 /-...e of Xpert(TM) vanA/vanB as a European CE,IVD Mark...Diagnostic,Medical Devices. The test delivers rapi...ost commonly associated with vancomycin-resistant,...
(Date:10/6/2008)...J., Oct. 6 /- Pharmasset, I...mith, Ph.D., is joining the,Company as Vice Presid...ions. Dr. Smith will be responsible for all invest... Chief Financial Officer Kurt,Leutzinger., Most r... Biotechnology,Analyst at JPMorgan Securities, and...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2Patients with chronic illness benefit from telehealth intervention 18715 1Patients with chronic illness benefit from telehealth intervention 18715 2
...ESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasda...the scalable production, survival following engraf...nfarcted rats was presented,today for GRNCM1, the ...herapeutic for heart failure, at the International...ting in Cairns,Australia., The presentation was o...
...ne 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corp...ter,on trodusquemine (MSI-1436), its novel anti-ob...iation (ADA) 67th Scientific,Sessions, June 22 to ..., "Trodusquemine is a Multiple,Pathway Inhibitor t...sity, and Improves Plasma Insulin and Leptin Level...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: